摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-nitro-4-anilinoquinazoline | 171744-89-1

中文名称
——
中文别名
——
英文名称
7-nitro-4-anilinoquinazoline
英文别名
7-nitro-N-phenylquinazolin-4-amine;(7-nitro-quinazolin-4-yl)-phenyl-amine;(7-Nitro-chinazolin-4-yl)-phenyl-amin
7-nitro-4-anilinoquinazoline化学式
CAS
171744-89-1
化学式
C14H10N4O2
mdl
——
分子量
266.259
InChiKey
FHPNEDYOQKPVMZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    83.6
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-nitro-4-anilinoquinazoline溶剂黄146 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以19%的产率得到N4-phenylquinazoline-4,7-diamin
    参考文献:
    名称:
    评估用于化学蛋白质组学应用的位点多样化、完全功能化的二氮丙啶探针
    摘要:
    基于几种已上市的 EGFR 靶向药物共享的支架,构建了一系列位点多样化、功能齐全的二氮丙啶探针。位点多样化探针工具包对蛋白质靶点的综合分析不仅揭示了更完整的靶点空间并有助于提示假阳性靶点,而且揭示了多域靶点-配体相互作用的动态事件。
    DOI:
    10.1039/d2cc03868d
  • 作为产物:
    描述:
    2-氨基-4-硝基苯甲酸氯化亚砜甲酸铵 作用下, 以 N,N-二甲基甲酰胺异丙醇 为溶剂, 反应 18.5h, 生成 7-nitro-4-anilinoquinazoline
    参考文献:
    名称:
    苯基脲偶联喹唑啉类化合物及其制备方法、药 物组合物及药物用途
    摘要:
    本发明提供一种式(I)所示的苯基脲偶联喹唑啉类化合物或其药学上可接受的盐,其中,R1为H;Br、Cl或F;‑CH3、‑CH2‑CH3、‑CH2(CH3)2或‑CF3;‑O‑CH3、‑O‑CH2‑CH3或‑O‑CH2(CH3)2;‑C≡CH或‑C≡N;n1为1、2、3、4或5;R2或R3之一为式(II)所示的基团;R4为H;Br、Cl或F;‑CH3、‑CH3‑CH3、‑CH2(CH3)2或‑CF3;‑O‑CH3、‑O‑CH2‑CH3或‑O‑CH2(CH3)2;‑NH2;或‑NO2;n2为1、2、3、4或5;R2或R3中的另外一个为H、‑O‑CH3、‑O‑CH2‑CH3、‑O‑CH2(CH3)2、或
    公开号:
    CN103382182B
点击查看最新优质反应信息

文献信息

  • 苯基脲偶联喹唑啉类化合物及其制备方法、药 物组合物及药物用途
    申请人:河北医科大学
    公开号:CN103382182B
    公开(公告)日:2016-08-10
    本发明提供一种式(I)所示的苯基脲偶联喹唑啉类化合物或其药学上可接受的盐,其中,R1为H;Br、Cl或F;‑CH3、‑CH2‑CH3、‑CH2(CH3)2或‑CF3;‑O‑CH3、‑O‑CH2‑CH3或‑O‑CH2(CH3)2;‑C≡CH或‑C≡N;n1为1、2、3、4或5;R2或R3之一为式(II)所示的基团;R4为H;Br、Cl或F;‑CH3、‑CH3‑CH3、‑CH2(CH3)2或‑CF3;‑O‑CH3、‑O‑CH2‑CH3或‑O‑CH2(CH3)2;‑NH2;或‑NO2;n2为1、2、3、4或5;R2或R3中的另外一个为H、‑O‑CH3、‑O‑CH2‑CH3、‑O‑CH2(CH3)2、或
  • COMPOUNDS AND METHODS FOR INHIBITING VACUOLAR ATPASE
    申请人:ZHANG Chao
    公开号:US20170174638A1
    公开(公告)日:2017-06-22
    A compound of Formula II, is provided. R 1 , R 2 and R 3 are independently either hydrogen, alkyl, aryl, halogen, alkoxy, nitro, amino or hydroxyl. X is either F, Cl, Br, I or CN. Y is either N or CH. Compositions that include Formula II can be used to inhibit vacuolar H + ATPase.
    提供了一种化合物,其化学式为II。R1、R2和R3可以独立地是氢、烷基、芳基、卤素、烷氧基、硝基、氨基或羟基。X可以是F、Cl、Br、I或CN。Y可以是N或CH。包含化学式II的组合物可用于抑制液泡H+ATPase。
  • 88. The chemistry of simple heterocyclic systems. Part I. Reactions of 6- and 7-nitro-4-hydroxyquinazoline and their derivatives
    作者:J. S. Morley、J. C. E. Simpson
    DOI:10.1039/jr9480000360
    日期:——
  • Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3
    作者:Alvin Kung、Ying-Chu Chen、Marianne Schimpl、Feng Ni、Jianfa Zhu、Maurice Turner、Henrik Molina、Ross Overman、Chao Zhang
    DOI:10.1021/jacs.6b05483
    日期:2016.8.24
    Erythropoietin-producing human hepatocellular carcinoma (Eph) receptor tyrosine kinases (RTKs) regulate a variety of dynamic cellular events, including cell protrusion, migration, proliferation, and cell fate determination. Small-molecule inhibitors of Eph kinases are valuable tools for dissecting the physiological and pathological roles of Eph. However, there is a lack of small-molecule inhibitors that are selective for individual Eph isoforms due to the high homology within the family. Herein, we report the development of the first potent and specific inhibitors of a single Eph isoform, EphB3. Through structural bioinformatic analysis, we identified a cysteine in the hinge region of the EphB3 kinase domain, a feature that is not shared with any other human kinases. We synthesized and characterized a series of electrophilic quinazolines to target this unique, reactive feature in EphB3. Some of the electrophilic quinazolines selectively and potently inhibited EphB3 both in vitro and in cells. Cocrystal structures of EphB3 in complex with two quinazolines confirmed the covalent linkage between the protein and the inhibitors. A "clickable" version of an optimized inhibitor was created and employed to verify specific target engagement in the whole proteome and to probe the extent and kinetics of target engagement of existing EphB3 inhibitors. Furthermore, we demonstrate that the autophosphorylation of EphB3 within the juxtamembrane region occurs in trans using a specific inhibitor. These exquisitely specific inhibitors will facilitate the dissection of EphB3's role in various biological processes and disease contribution.
  • Evaluation of site-diversified, fully functionalized diazirine probes for chemical proteomic applications
    作者:Yan Tan、Songsen Fu、Tao Yang、Yuxin Xie、Guyi Shen、Jie Yan、Yufen Zhao、Feng Ni
    DOI:10.1039/d2cc03868d
    日期:——
    A series of site-diversified, fully functionalized diazirine probes are constructed based on a scaffold shared by several marketed EGFR-targeted drugs. The integrated analysis of protein targets of the site-diversified probe toolkit not only unveils more complete target space and helps suggest false positive targets, but also reveals dynamic events of multi-domain target-ligand interaction.
    基于几种已上市的 EGFR 靶向药物共享的支架,构建了一系列位点多样化、功能齐全的二氮丙啶探针。位点多样化探针工具包对蛋白质靶点的综合分析不仅揭示了更完整的靶点空间并有助于提示假阳性靶点,而且揭示了多域靶点-配体相互作用的动态事件。
查看更多